Home Health Care News February 14, 2025
Tim Mullaney

Recent developments in the legal battle over the planned $3.3 billion UnitedHealth Group (NYSE: UHG) acquisition of Amedisys (Nasdaq: AMED) have moved the case closer to trial and shed more light on how UnitedHealth and Amedisys are pursuing divestments and defending the transaction.

First, UnitedHealth dropped its motion to dismiss the case, saying that the U.S. Department of Justice (DOJ)–which is suing the block the deal–had produced more detailed information about which counties the government alleges will be particularly harmed by weakened home health competition, should the acquisition be consummated.

Then, UnitedHealth on Feb. 7 filed its response to the DOJ’s complaint. Among other information, the response included more precise information about the number of locations that UnitedHealth and Amedisys...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Insurance, Mergers & Acquisitions / JV, Payer, Post-Acute Care, Provider, Trends
Related Articles:
Aetna Taps InStride Health for Specialty Youth Mental Health
Where 13 payers are growing in 2025
Humana Expands Into Four New Senior Primary Care Markets
Humana plans to add 30 more primary care centers this year
UnitedHealthcare looks to cut jobs

Share This Article